Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost ...

Distinct psychiatric disorders have more in common biologically than previously believed, according to the largest and most detailed analysis to date of how genes influence mental illness. The study, ...

Distinct psychiatric disorders have more in common biologically than previously believed, according to the largest and most detailed analysis to date of how genes influence mental illness. The study, ...

A team of researchers led by scientists from the Icahn School of Medicine at Mount Sinai, SUNY Downstate Health Sciences University, and the Department of Veterans Affairs has conducted the largest ...

Study focused on ‘Goldilocks Gene’ CHD2 that causes autism and epilepsy Deletion of long non-coding RNA CHASERR produces too much CHD2 protein in the cell, leaving patients wheelchair-bound, nonverbal ...

A groundbreaking new study has revealed that eight major psychiatric disorders may share a common genetic foundation. Conducted by a US-based research team, the study identified specific genetic ...

OSAKA, Japan & SACRAMENTO, Calif.--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, PhD.; hereinafter “Shionogi ...

People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms. By ...

Amongst the political shockwaves that have to date characterized President Donald Trump’s first few weeks back in the Oval Office, it is likely to be the proposed changes to medical research funding ...

For decades, scientists have been trying to unravel the mysteries of restless legs syndrome (RLS), a poorly understood and underdiagnosed neurological disorder causing itching, crawling, and aching ...

Evidence is mounting that clinicians can treat serious genetic disorders prenatally by injecting medicine into the amniotic fluid, thus preventing damage that begins in utero. A UC San Francisco-led ...